Liu Baolai, Fan Keyi, Zheng Xinyi, Zhang Yaochen, Bai Shangkai, Liu Zhentong, Xu Shuhan, Su Zhihao, Cao Huiting, Zhang Heyi, Zhang Shengxiao
Department of Neurosurgery, Shanxi Provincial People's Hospital, The Affiliated People's Hospital of Shanxi Medical University, Taiyuan, China.
Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan, Shanxi, China.
Front Neurol. 2024 Aug 12;15:1376314. doi: 10.3389/fneur.2024.1376314. eCollection 2024.
Observational studies have suggested that a multitude of pathological processes and biomolecules are involved in the initiation and development of epilepsy, and ULK3 is linked to the nervous system. However, it remains uncertain whether this association between ULK3 and epilepsy is causal and the direction of any causal relationship. This study employs a two-sample Mendelian randomization (MR) method to investigate the relationship between ULK3 and the risk of epilepsy.
We analyzed genome-wide association study (GWAS) summary statistics for ULK3 (sample size = 3,301), focal epilepsy (sample size = 39,348), and generalized epilepsy (sample size = 33,446). Bidirectional MR analyses were conducted to explore these relationships. We selected a set of single nucleotide polymorphisms (SNPs) with an association threshold of less than 1 × 10 as instrumental variables for further analysis. Various MR methods, including Inverse Variance Weighted, Weighted Median, MR-Egger Regression, Simple Model, Weighted Model, and Robust Adjustment Profile Score were used. Sensitivity analyses were performed to ensure the robustness of the results.
Our MR analyses revealed a causal relationship where an increased level of ULK3 was associated with a decreased risk of focal epilepsy (odds ratio = 0.92, 95% confidence interval: 0.86-1.00, = 0.041). No significant heterogeneity (Q = 7.85, = 0.165) or horizontal pleiotropy (Egger regression intercept = 0.0191, = 0.415) was detected. However, in the reverse analysis, we found no significant causal effect of focal epilepsy on ULK3 ( > 0.05). Furthermore, no significant causation was identified between ULK3 and generalized epilepsy ( > 0.05).
This study suggests a causal relationship between ULK3 and the risk of focal epilepsy from a genetic perspective. Nevertheless, further investigation is needed to understand the role of ULK3 in epilepsy fully.
观察性研究表明,多种病理过程和生物分子参与癫痫的发生和发展,且ULK3与神经系统有关联。然而,ULK3与癫痫之间的这种关联是否具有因果关系以及任何因果关系的方向仍不确定。本研究采用两样本孟德尔随机化(MR)方法来研究ULK3与癫痫风险之间的关系。
我们分析了ULK3(样本量 = 3301)、局灶性癫痫(样本量 = 39348)和全身性癫痫(样本量 = 33446)的全基因组关联研究(GWAS)汇总统计数据。进行双向MR分析以探索这些关系。我们选择了一组关联阈值小于1×10的单核苷酸多态性(SNP)作为工具变量进行进一步分析。使用了多种MR方法,包括逆方差加权法、加权中位数法、MR-Egger回归法、简单模型法、加权模型法和稳健调整轮廓评分法。进行敏感性分析以确保结果的稳健性。
我们的MR分析揭示了一种因果关系,即ULK3水平升高与局灶性癫痫风险降低相关(优势比 = 0.92,95%置信区间:0.86 - 1.00,P = 0.041)。未检测到显著的异质性(Q = 7.85,P = 0.165)或水平多效性(Egger回归截距 = 0.0191,P = 0.415)。然而,在反向分析中,我们发现局灶性癫痫对ULK3没有显著的因果效应(P > 0.05)。此外,未发现ULK3与全身性癫痫之间存在显著的因果关系(P > 0.05)。
本研究从遗传学角度表明ULK3与局灶性癫痫风险之间存在因果关系。然而,需要进一步研究以全面了解ULK3在癫痫中的作用。